Deal of the Day — limited-time pharmacy picks!
Imatikast 100mg Tablet

Imatikast 100mg Tablet

Prescription requiredRx Required

Salt Composition: Imatinib

Expiry Date: 01/2028

Special offer

Buy at $2.42

$2.42

Inclusive of all taxes

▼

10 Tablet(s) In A Strip

About The Product

​Blood Cancer

Description

Imatikast 100mg tablet is a prescription-based medication prescribed by a healthcare professional. It is used in the treatment of Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GISTs).

Its active ingredient is Imatinib, which belongs to the drug class of Tyrosine kinase inhibitors, which stops the production of cancer cells and blocks the site of cancer formation in the body. The medication should be correctly administered by a healthcare professional, and always follow the prescription-based medication.

It should be recommended to patients to both adults and children.

Uses

  • Chronic Myeloid Leukemia (CML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Gastrointestinal Stromal Tumors (GISTs)

Side Effects

Every medication causes common as well as severe side effects that are harmful to the patient's body. Consult a healthcare professional if some symptoms are noticed:

  • Muscle cramps and pain
  • Diarrhea
  • Skin rash, night sweats
  • Tiredness, dizziness
  • Abdominal pain
  • Increased weight
  • Decreased RBC and WBC cells
  • Headache
  • Cough, Inflammation in the nose
  • Fever, lack of sleep

  • Heart failure
  • GI disorders
  • Hypothyroidism
  • Liver failure
  • Swelling in the body

  • Swelling in the face, legs, ankles, and feet
  • Nausea, vomiting

How To Use

  • Taking Imatikast 100mg tablet with a whole glass of water, do not crush, chew or break the tablet as this may affect its effectiveness and increase the risk of side effects.Never self administered on the dosages and duration as doctor guides better according to the patients height, weight and response to the treatment.
  • Always the recommended dosages as prescribed by the healthcare professional.

How It Works

Imatikast 100mg tablet helps control disease progression by inhibiting the BCR- ABL tyrosine kinase enzyme,  which is responsible for uncontrolled growth of cancer cells in the body. By blocking the enzyme, the medicine helps stop the proliferation of malignant cells. As a result, it stops the cancer cells from spreading to other body parts and prevents the body from further growing tumors in the body.

Safety Advice

Alcohol
Taking Imatikast 100mg tablet with alcohol may be dangerous to the patient's health but consult the doctor before taking the medication.
Pregnancy
Imatikast 100mg tablet is not recommended for pregnant women as it may affect the fetus or newborn. Take guidance from a healthcare expert to ensure safety and precautions.
Breast Feeding
Breastfeeding women should not be advisable for taking Imatikast 100mg tablet as the medicine is passed through breast that somehow affect breast milk. Discuss with the doctor for more query.
Driving
Imatikast 100mg tablet may not cause dizziness or sleepiness but patient may still experience some side effects. It is important to monitor the response of medication and report any unusual symptoms to the doctor.
Kidney
Kidney patients should take precautions while using Imatikast 100mg tablet as dose adjustment and doctor's prescription is much needed.
Liver
Imatikast 100mg tablet is unsafe for liver patients as this may cause common as well as severe side effects. Consult the healthcare supervision for proper medical attention.

FAQs

Imatikast 100mg tablet should be used by the patient of Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GISTs)

References

  • Peng, B., Lloyd, P., & Schran, H. (2005). Clinical pharmacokinetics of imatinib. Clinical pharmacokinetics, 44(9), 879-894. https://pubmed.ncbi.nlm.nih.gov/16122278/
  • Lyseng-Williamson, K., & Jarvis, B. (2001). Imatinib. Drugs, 61(12), 1765-1774.. https://pmc.ncbi.nlm.nih.gov/articles/PMC2394355/
  • Nikolova, Z., Peng, B., Hubert, M., Seiberling, M., Keller, U., Ho, Y. Y., ... & Capdeville, R. (2004). Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. Cancer chemotherapy and pharmacology, 53(5), 433-438. https://pubmed.ncbi.nlm.nih.gov/15132131/
  • BOGURADZKI, P. BIOEQUIVALENCE STUDY OF 400 AND 100 MG IMATINIB FILM-COATED TABLETS IN HEALTHY VOLUNTEERS. https://pubmed.ncbi.nlm.nih.gov/25362813/
  • Ma, Z., Zhao, J., Li, S., Gao, F., Zhang, C., Wu, L., & Lin, Y. (2024). Imatinib-induced ulcerative colitis. Journal of Oncology Pharmacy Practice, 30(6), 1111-1117. https://pubmed.ncbi.nlm.nih.gov/38772691/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026